Literature DB >> 21235667

Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors.

Can Hasdemir1, Cem Ulucan, Oguz Yavuzgil, Alper Yuksel, Yildirim Kartal, Evrim Simsek, Oktay Musayev, Meral Kayikcioglu, Serdar Payzin, Hakan Kultursay, Mehmet Aydin, Levent H Can.   

Abstract

INTRODUCTION: Idiopathic ventricular arrhythmias in the form of monomorphic premature ventricular contractions (PVC) and/or ventricular tachycardia (VT) can cause tachycardia-induced cardiomyopathy (TICMP). The aim of this study was to determine the incidence, clinical and electrophysiologic characteristics, and the predictors of TICMP in patients with idiopathic ventricular arrhythmias.
METHODS: Study population consisted of 249 consecutive patients (148 F/101 M, 45 ± 20 y/o) with frequent PVCs and/or VT. All patients underwent transthoracic echocardiography and 24-hour Holter monitoring. TICMP was defined as left ventricular ejection fraction (LVEF) of ≤50% in the absence of any detectable underlying heart disease and improvement of LVEF ≥15% following effective treatment of index ventricular arrhythmia.
RESULTS: Seventeen (6.8%) patients had TICMP. Patients with TICMP compared to patients with preserved LVEF were more likely to be male (65% vs 39%, P = 0.043) and asymptomatic (29% vs 9%, P = 0.018), and were more likely to have higher PVC burden (29.4 ± 9.2 vs 8.1 ± 7.4, P < 0.001), persistence of PVCs throughout the day (65% vs 22%, P = 0.001), and repetitive monomorphic VT (24% vs 0.9%, P < 0.001). PVC burden of 16% by ROC curve analysis best separated the patients with TICMP compared to patients with preserved LVEF (sensitivity 100%, specificity 87%, area under curve 0.96).
CONCLUSIONS: TICMP was relatively common (∼1 in every 15 patients) in our study population. The predictors of TICMP were male gender, absence of symptoms, PVC burden of ≥16%, persistence of PVCs throughout the day, and the presence of repetitive monomorphic VT.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21235667     DOI: 10.1111/j.1540-8167.2010.01986.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  34 in total

1.  Impact of radiofrequency catheter ablation on echocardiographic and cardiopulmonary performance in patients with ventricular extrasystolic beats and suspected arrhythmia-induced cardiomyopathy.

Authors:  Tomasz Krynski; Sebastian Stec; Sebastian Szmit; Beata Zaborska; Paweł Balsam; Piotr Kulakowski; Grzegorz Opolski
Journal:  Heart Vessels       Date:  2014-11       Impact factor: 2.037

Review 2.  Idiopathic VPC: Distribution Of FOCI And Tips Of Ablation.

Authors:  Jose C Pachon M; Tasso J Lobo; Enrique I Pachon M; Tomas G Santillana P; Carlos Tc Pachon; Juan C Pachon M; Remy N Albornoz V; Juan C Zerpa A; Felipe A Ortencio
Journal:  J Atr Fibrillation       Date:  2016-04-30

Review 3.  [Current strategies in the treatment of ventricular tachycardia by catheter ablation : A review].

Authors:  S Koenig; A Arya; G Hindricks; B Dinov
Journal:  Herz       Date:  2017-09-07       Impact factor: 1.443

Review 4.  Frequent Premature Ventricular Contractions and Cardiomyopathy, Chicken and Egg situation.

Authors:  Kıvanç Yalin; Ebru Gölcük
Journal:  J Atr Fibrillation       Date:  2017-08-31

5.  Premature ventricular contractions activate vagal afferents and alter autonomic tone: implications for premature ventricular contraction-induced cardiomyopathy.

Authors:  Siamak Salavatian; Naoko Yamaguchi; Jonathan Hoang; Nicole Lin; Saloni Patel; Jeffrey L Ardell; J Andrew Armour; Marmar Vaseghi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-19       Impact factor: 4.733

Review 6.  Arrhythmia-Induced Cardiomyopathy.

Authors:  Samuel Sossalla; Dirk Vollmann
Journal:  Dtsch Arztebl Int       Date:  2018-05-11       Impact factor: 5.594

Review 7.  Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.

Authors:  Jose F Huizar; Kenneth A Ellenbogen; Alex Y Tan; Karoly Kaszala
Journal:  J Am Coll Cardiol       Date:  2019-05-14       Impact factor: 24.094

8.  Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia.

Authors:  Zhao Donghua; Peng Jian; Xiao Zhongbo; Zhang Feifei; Peng Xinhui; Yang Hao; Liu Fuqiang; Li Yan; Xie Yong; Huang Xinfu; Meng Surong; Wu Muli; Xu Dingli
Journal:  J Interv Card Electrophysiol       Date:  2012-10-23       Impact factor: 1.900

Review 9.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12

10.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.